Pre-made Technetium (99Mtc) Fanolesomab benchmark antibody (Radiolabelled antibody, anti-CD15 therapeutic antibody, Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Technetium (99Mtc) Fanolesomab benchmark antibody (Radiolabelled antibody, anti-CD15 therapeutic antibody, Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Technetium (99mTc) fanolesomab (trade name NeutroSpec, manufactured by Palatin Technologies) is a mouse monoclonal antibody formerly used to aid in the diagnosis of appendicitis. It is labeled with a radioisotope, technetium-99m (99mTc).

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-1011-1mg	1mg	3090
GMP-Bios-INN-1011-10mg	10mg	Inquiry
GMP-Bios-INN-1011-100mg	100mg	Inquiry
GMP-Bios-INN-1011-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Technetium (99Mtc) Fanolesomab Biosimilar, Radiolabelled Antibody, Anti-Cd15 Antibody: Anti-ELFT/FCT3A/FUC-TIV/FUTIV/LeX/SSEA-1 therapeutic antibody
INN Name	Technetium (99Mtc) Fanolesomab
Target	CD15
Format	Radiolabelled antibody
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	IgM - nd
VD LC	IgM - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Palatin Technologies Inc. (Cranbury NJ USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0